DHR Danaher Corporation
Healthcare$172.81+0.47%ClosedMarket Cap: $122.31B
As of 2026-05-26
Valuation
P/E (TTM)
37.10
PEG
—
P/B
2.30
P/S
4.91
EV/EBITDA
20.11
DCF Value
$219.45
FCF Yield
4.3%
Div Yield
0.8%
Margins & Returns
Gross Margin
60.7%
Operating Margin
21.0%
Net Margin
14.9%
ROE
7.1%
ROA
4.4%
ROIC
5.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $5.95B | 60.3% | $1.34B | $1.03B | $— | $0.72 |
| Q4 null | $6.84B | 58.0% | $1.50B | $1.20B | $— | $0.32 |
| FY null | $24.57B | 60.9% | $5.14B | $3.61B | $— | $1.55 |
| Q3 null | $6.05B | 58.2% | $1.15B | $908.0M | $— | $0.64 |
| Q2 null | $5.94B | 66.6% | $1.19B | $555.0M | $— | $0.64 |
| Q1 null | $5.74B | 61.4% | $1.29B | $954.0M | $— | $0.59 |
| Q4 null | $6.54B | 59.5% | $1.75B | $1.09B | $— | $0.54 |
| FY null | $23.88B | 59.5% | $5.18B | $3.90B | $— | $1.32 |
| Q3 null | $5.80B | 58.7% | $958.0M | $818.0M | $— | $0.54 |
| Q2 null | $5.74B | 59.7% | $1.17B | $907.0M | $— | $0.54 |
| Q1 null | $5.80B | 60.2% | $1.31B | $1.09B | $— | $0.51 |
| Q4 2023 | $6.41B | 59.0% | $1.41B | $1.08B | $1.45 | $0.51 |